Nicox has announced the US launch of its rapid point-of-care diagnostic test, designed for the detection of acute conjunctivitis. The FDA-cleared and CLIA-waived assay, AdenoPlus, uses its four-step process to detect adenovirus and ...
Tags: rapid point-of-care diagnostic test, FDA, medical devices